COVID-19 Vaccine Acceptance and its Determinants among Adult Population of Chengalpattu District: A Mixed-method Study
Abstract
Background: India has introduced a new COVID-19 vaccine recently which is made primarily available for healthcare workers and frontline workers. Globally, few other vaccines were also been approved against the SARS-CoV-2, whereas only little is known about its acceptance in the community. However, vaccine hesitancy is a public health threat. Therefore, this study was aimed to assess the acceptance of the COVID-19 vaccine and its determinants.
Method: A mixed-method design starting with a cross-sectional study using a pre-tested, semi-structured questionnaire between December 2020 – January 2021 among adults (18 years and above) residing in Chengalpattu followed by a qualitative approach with five key informant interviews was planned. Based on previous studies, the sample size was approximated to 140 which was collected through a simple random sampling method. Collected data were analysed using IBM-SPSS, v21.0. Statistical significance was described using the chi-square test, p < 0.05 was considered significant.
Results: Among the 140 respondents, the majority 56 (40%) had acceptance of the COVID-19 vaccine while 34 (24.3%) were inconclusive of their decision on vaccine acceptance. The most preferred characteristics of the COVID-19 vaccine felt by those showing willingness to vaccinate were both minimal side effects and cost-effectiveness 24 (42.9%). The majority 33 (58.9%) of the respondent’s decision-making depends on the doctor’s recommendation regarding vaccination. Statistical significance (p < 0.008) was perceived among gender and vaccine acceptance.
Conclusion: A large proportion decided to delay vaccination due to increased concern about vaccine side effects reported in various other countries. This concern should be dealt with to develop an effective mass vaccination strategy against the COVID-19 and increase vaccine coverage.
How to cite this article:
Raja D, Sasithra S. COVID-19 Vaccine Acceptance and its Determinants among Adult Population of Chengalpattu District: A Mixed-method Study. Special Issue - COVID-19 & Other Communicable Disease. 2022;68-74.
DOI: https://doi.org/10.24321/0019.5138.202211
References
World Health Organization [Internet]. Coronavirus disease (COVID-19); 2021 [cited 2021 Jan 3]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19
World Health Organization [Internet]. WHO Coronavirus Disease (COVID-19) Dashboard; 2021 [cited 2021 Jan 3]. Available from: https://covid19.who.int/
COVIDIndia.org [Internet]. Tamil Nadu - Latest COVID-19 cases, hotspot zones, and testing centers; 2021 [cited 2021 Jan 3]. Available from: https://www.covid19india.org/state/TN
World Health Organization [Internet]. COVID-19 vaccines; 2021 [cited 2021 Jan 29]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
World Health Organization [Internet]. Ten health issues WHO will tackle this year; 2021 [cited 2021 Jan 3]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
World Health Organization [Internet]. Immunization coverage; 2021 [cited 2021 Jan 29]. Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
Randolph H, Barreiro L. Herd immunity: Understanding COVID-19. Immunity. 2020 May;52(5):737-41. [PubMed] [Google Scholar]
World Health Organization [Internet]. Coronavirus disease (COVID-19): vaccines; 2021 [cited 2021 Jan 3]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice
World Health Organization [Internet]. Coronavirus disease (COVID-19): vaccine access and allocation; 2021 [cited 2021 Jan 15]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccine-access-and-allocation
The Times of India [Internet]. Dry run of Covid-19 vaccine in all states today: All you need to know; 2021 [cited 2021 Jan 30]. Available from: https://timesofindia.indiatimes.com/india/dry-run-of-covid-19-vaccine-to-begin-in-all-states-today-all-you-need-to-know/articleshow/80067553.cms
The Hindu [Internet]. Coronavirus | First phase of vaccination to start on January 16; 2021 [cited 2021 Jan 30]. Available from: https://www.thehindu.com/news/national/india-to-start-covid-19-vaccination-drive-on-jan-16/article33536670.ece
Fu C, Wei Z, Pei S, Li S, Sun X, Liu P. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). medRxiv [Preprint]. 2020. [cited 2021 Jan 3]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.09.20060103v1 [Google Scholar]
Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020 Aug;8(3):482. [PubMed] [Google Scholar]
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225-8. [PubMed] [Google Scholar]
National Council of Applied Economic Research [Internet]. National Data Innovation Centre (NDIC); 2021 [cited 2021 Jan 30]. Available from: https://www.ncaer.org/data_details.php?dID=28
Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020 Aug;35(8):775-9. [PubMed] [Google Scholar]
Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020 Oct;38(45):7002-6. [PubMed] [Google Scholar]
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020 Nov;13:1657-63. [PubMed] [Google Scholar]
Gidengil CA, Parker AM, Zikmund-Fisher BJ. Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic. Am J Public Health. 2012 Apr;102(4):672-9. [PubMed] [Google Scholar]
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020 Jul;8:381. [PubMed] [Google Scholar]
Gadoth A, Halbrook M, Martin-Blais R, Gray A, Tobin NH, Ferbas KG, Aldrovandi GM, Rimoin AW. Assessment of COVID-19 vaccine acceptance among healthcare workers in Los Angeles. Ann Intern Med. 2021 Jun;174(6):882-5. [PubMed] [Google Scholar]
Kishore J, Venkatesh U, Ghai G, Heena, Kumar P. Perception and attitude towards COVID-19 vaccination: a preliminary online survey from India. J Family Med Prim Care. 2021 Aug;10:3116-21. [PubMed] [Google Scholar]
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Vo TQ, Hadisoemarto PF, Müller R, Groneberg DA, Mudatsir M. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccin Immunother. 2020 Dec;16(12):3074-80. [PubMed] [Google Scholar]
Copyright (c) 2022 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
